Catecholaminergic polymorphic ventricular tachycardia: genes and variants
Explore variant evidence for Catecholaminergic polymorphic ventricular tachycardia across 5 analyzed proteins (RYR2, CALM1, CASQ2, TRDN, TECRL). Linked ClinVar records include 78 pathogenic or likely pathogenic variants, 1,951 variants of uncertain significance and 126 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Catecholaminergic polymorphic ventricular tachycardia
RYR2: Ryanodine receptor 2
It releases calcium from the cardiac sarcoplasmic reticulum in response to trigger calcium entering during each action potential, thereby initiating contraction. Pathogenic variants can destabilize calcium release and are a major cause of catecholaminergic polymorphic ventricular tachycardia.
58 ClinVar pathogenic / likely pathogenic and 1,574 uncertain variants in RYR2 have source records linked to Catecholaminergic polymorphic ventricular tachycardia. Association strength is not clinical gene validity.
CALM1: Calmodulin-1
It translates intracellular calcium signals into changes in the activity of ion channels, kinases, phosphatases, and many other targets. De novo missense variants can cause severe calmodulinopathy, particularly long-QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.
11 ClinVar pathogenic / likely pathogenic and 10 uncertain variants in CALM1 have source records linked to Catecholaminergic polymorphic ventricular tachycardia. Association strength is not clinical gene validity.
CASQ2: Calsequestrin-2
It buffers calcium inside the cardiac sarcoplasmic reticulum and helps regulate calcium release through RYR2 during each heartbeat. Biallelic and some dominant pathogenic variants cause catecholaminergic polymorphic ventricular tachycardia by destabilizing intracellular calcium handling.
7 ClinVar pathogenic / likely pathogenic and 181 uncertain variants in CASQ2 have source records linked to Catecholaminergic polymorphic ventricular tachycardia. Association strength is not clinical gene validity.
TRDN: Triadin
It organizes the sarcoplasmic-reticulum calcium-release complex and helps couple calsequestrin and ryanodine receptors in cardiac and skeletal muscle. Biallelic loss-of-function variants cause triadin knockout syndrome with severe exercise- or stress-triggered ventricular arrhythmias.
2 ClinVar pathogenic / likely pathogenic and 302 uncertain variants in TRDN have source records linked to Catecholaminergic polymorphic ventricular tachycardia. Association strength is not clinical gene validity.
TECRL: Trans-2,3-enoyl-CoA reductase-like
A membrane protein related to enoyl-CoA reductases whose precise biochemical function remains unclear. Biallelic pathogenic variants cause catecholaminergic polymorphic ventricular tachycardia type 3, an inherited arrhythmia triggered by physical or emotional stress.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in TECRL have source records linked to Catecholaminergic polymorphic ventricular tachycardia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MYBPC3, ANK2, DSP and GABRA1.
ClinVar pathogenic and likely pathogenic variants linked to Catecholaminergic polymorphic ventricular tachycardia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CASQ2 P308L | 308 | Pathogenic / likely pathogenic (★★) | |
| CASQ2 M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| CALM1 N98S | 98 | EF-hand 3 | Pathogenic / likely pathogenic (★★) |
| CASQ2 R33Q | 33 | Pathogenic / likely pathogenic (★★) | |
| RYR2 Y2392C | 2392 | 4 X approximate repeats | Pathogenic / likely pathogenic (★★) |
| TRDN M1T | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CALM1 F142L | 142 | EF-hand 4 | Pathogenic / likely pathogenic (★★) |
| RYR2 A391D | 391 | MIR 5 | Pathogenic / likely pathogenic (★★) |
| RYR2 R2474G | 2474 | 4 X approximate repeats | Pathogenic / likely pathogenic (★★) |
| RYR2 V3875L | 3875 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| RYR2 Y4149C | 4149 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| RYR2 V4771F | 4771 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CASQ2 Y55C | 55 | Pathogenic / likely pathogenic (★★) | |
| CALM1 D96Y | 96 | EF-hand 3 | Pathogenic / likely pathogenic (★) |
| CALM1 D96V | 96 | EF-hand 3 | Pathogenic / likely pathogenic (★) |
| CALM1 D96G | 96 | EF-hand 3 | Pathogenic / likely pathogenic (★) |
| CALM1 D132V | 132 | EF-hand 4 | Pathogenic / likely pathogenic (★) |
| CALM1 D132G | 132 | EF-hand 4 | Pathogenic / likely pathogenic (★) |
| CALM1 D132N | 132 | EF-hand 4 | Pathogenic / likely pathogenic (★) |
| RYR2 F4600I | 4600 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CALM1 F90L | 90 | EF-hand 3 | Pathogenic / likely pathogenic (★) |
| RYR2 D2300H | 2300 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 D2300E | 2300 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 F4600L | 4600 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CALM1 G133E | 133 | EF-hand 4 | Pathogenic / likely pathogenic (★) |
| RYR2 I419F | 419 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 Q3955K | 3955 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 D4646E | 4646 | Pathogenic / likely pathogenic (★) | |
| RYR2 V4880A | 4880 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 D400A | 400 | MIR 5 | Pathogenic / likely pathogenic (★) |
| RYR2 D400G | 400 | MIR 5 | Pathogenic / likely pathogenic (★) |
| RYR2 N2291K | 2291 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 P4090A | 4090 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 H4742Q | 4742 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CALM1 N54I | 54 | EF-hand 2 | Pathogenic / likely pathogenic (★) |
| CASQ2 M1I | 1 | Pathogenic / likely pathogenic (★) | |
| RYR2 G605V | 605 | B30.2/SPRY 1 | Pathogenic / likely pathogenic (★) |
| RYR2 Q3861H | 3861 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 L3935F | 3935 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 S4153R | 4153 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 V4880I | 4880 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 C47R | 47 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 P164S | 164 | MIR 1 | Pathogenic / likely pathogenic (★) |
| RYR2 E189D | 189 | MIR 2 | Pathogenic / likely pathogenic (★) |
| RYR2 T415I | 415 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 A549V | 549 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 C2201Y | 2201 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 Q2211P | 2211 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 D2216G | 2216 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 N2250I | 2250 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 V2306F | 2306 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 E2405K | 2405 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 I2419T | 2419 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 L2426R | 2426 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 L2527W | 2527 | 4 X approximate repeats | Pathogenic / likely pathogenic (★) |
| RYR2 P3612L | 3612 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 Q3774R | 3774 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 E3815G | 3815 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 E3987Q | 3987 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| RYR2 F4087L | 4087 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
Showing 60 of 78.
Uncertain variants prioritized for review in Catecholaminergic polymorphic ventricular tachycardia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CASQ2 P308Q | 308 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P308L at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.761 | |
| CALM1 G133A | 133 | EF-hand 4 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; G133E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.61 |
| CALM1 N98I | 98 | EF-hand 3 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; N98S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 |
Which prediction tools work for Catecholaminergic polymorphic ventricular tachycardia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- AlphaMissense: 94 out of 100
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 88 out of 100
- SIFT: 86 out of 100
- EVE: 86 out of 100
- MutPred: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 77 out of 100
- SpliceAI: 47 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 44 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Catecholaminergic polymorphic ventricular tachycardia
- Long QT syndrome, also linked to CALM1
- Arrhythmogenic right ventricular dysplasia, also linked to RYR2
- Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, also linked to RYR2
Frequently asked questions
Which genes have records linked to Catecholaminergic polymorphic ventricular tachycardia?
This view contains 5 analyzed proteins: RYR2, CALM1, CASQ2, TRDN, TECRL. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 78 pathogenic or likely pathogenic variants, 1,951 variants of uncertain significance and 126 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 2,343 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center